Schwager S.A. (SNSE:SCHWAGER)

CTI BioPharma Ratios and Metrics

Market cap in millions CLP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	36,394	23,880	16,813	13,099	11,726	7,372
Market Cap Growth	115.37%	42.03%	28.35%	11.71%	59.05%	53.12%
Enterprise Value	44,392	33,478	25,892	25,146	26,542	22,840
Last Close Price	1.62	1.04	0.70	0.53	0.48	0.51
PE Ratio	12.07	8.80	8.12	7.77	27.42	10.79
PS Ratio	0.39	0.25	0.21	0.19	0.23	0.14
PB Ratio	1.28	0.80	0.59	0.54	0.53	0.41
P/TBV Ratio	2.14	1.49	1.03	1.03	1.08	1.17
P/FCF Ratio	5.18	3.96	4.14	4.31	-	16.01
P/OCF Ratio	2.60	1.97	2.57	2.98	-	2.21
EV/Sales Ratio	0.48	0.36	0.32	0.36	0.52	0.43
EV/EBITDA Ratio	4.27	3.65	3.20	4.51	6.17	4.09
EV/EBIT Ratio	5.73	4.17	4.04	6.44	9.60	5.52
EV/FCF Ratio	6.32	5.55	6.37	8.28	-	49.59
Debt / Equity Ratio	0.26	0.41	0.33	0.37	0.50	0.72
Debt / EBITDA Ratio	0.70	1.30	1.11	1.54	2.46	2.20
Debt / FCF Ratio	1.03	2.05	2.30	2.96	-	27.87
Asset Turnover	1.47	1.51	1.51	1.42	1.09	1.23
Inventory Turnover	18.33	19.65	14.13	11.20	8.47	10.16
Quick Ratio	0.73	0.88	1.12	0.76	0.80	0.61
Current Ratio	1.04	1.14	1.56	1.23	1.26	1.07
Return on Equity (ROE)	14.73%	14.25%	13.93%	13.16%	5.25%	9.78%
Return on Assets (ROA)	7.64%	8.02%	7.42%	4.94%	3.68%	6.04%
Return on Capital (ROIC)	13.97%	12.50%	11.26%	7.34%	5.40%	8.60%
Return on Capital Employed (ROCE)	18.10%	17.90%	16.10%	11.80%	8.40%	13.60%
Earnings Yield	8.28%	11.37%	12.31%	12.87%	3.65%	9.27%
FCF Yield	19.29%	25.25%	24.17%	23.19%	-35.45%	6.25%
Dividend Yield	2.97%	4.61%	5.30%	-	-	-
Payout Ratio	39.41%	35.64%	15.22%	-	-	-
Buyback Yield / Dilution	2.80%	-	-13.03%	-	-65.83%	-
Total Shareholder Return	5.76%	4.61%	-7.74%	-	-65.83%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.